Drug Trial Radar · NCT03168334
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)
Last checked: Nov 19, 2026Latest source record: Apr 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
801
Actual
Start
Jul 11, 2017
Primary completion
Jul 24, 2018
Study completion Jul 24, 2018
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 30, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.
Conditions
- Acne Vulgaris
Interventions
IDP-123 LotionDrug
Tazarotene 0.045% Lotion
IDP-123 Vehicle LotionDrug
Vehicle Lotion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change in Mean Lesion Counts at Week 12Time frame: Baseline to Week 12
- Percentage of Subjects Who Had at Least a 2-grade Reduction From Baseline at Week 12 in the Evaluator's Global Severity Score (EGSS) and Had an EGSS at Week 12 That Equated to "Clear" or "Almost Clear"Time frame: Baseline to Week 12
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
Valeant Site 41
Mobile, Alabama
Valeant Site 22
Rogers, Arkansas
Valeant Site 34
Carlsbad, California
Valeant Site 12
Fremont, California
Valeant Site 06
San Diego, California
Valeant Site 13
San Diego, California
Valeant Site 31
San Diego, California
Valeant Site 36
Santa Ana, California
Valeant Site 25
Denver, Colorado
Valeant Site 05
Boynton Beach, Florida
Valeant Site 29
Clearwater, Florida
Valeant Site 38
Jupiter, Florida
Valeant Site 02
Miami, Florida
Valeant Site 26
West Palm Beach, Florida
Valeant Site 44
Snellville, Georgia
Valeant Site 32
Louisville, Kentucky
Valeant Site 19
Rockville, Maryland
Valeant Site 08
Bay City, Michigan
Valeant Site 30
Clarkston, Michigan
Valeant Site 37
Clinton Township, Michigan
Valeant Site 20
Fort Gratiot, Michigan
Valeant Site 24
Fridley, Minnesota
Valeant Site 03
Morristown, New Jersey
Valeant Site 42
Albuquerque, New Mexico
Valeant Site 10
New York, New York
Valeant Site 43
Rochester, New York
Valeant Site 33
Stony Brook, New York
Valeant Site 11
Oklahoma City, Oklahoma
Valeant Site 28
Broomall, Pennsylvania
Valeant Site 16
Warwick, Rhode Island
Valeant Site 18
Knoxville, Tennessee
Valeant Site 14
Murfreesboro, Tennessee
Valeant Site 23
College Station, Texas
Valeant Site 07
Dallas, Texas
Valeant Site 27
Pflugerville, Texas
Valeant Site 04
San Antonio, Texas
Valeant Site 39
Sugar Land, Texas
Valeant Site 09
Layton, Utah
Valeant Site 15
West Jordan, Utah
Valeant Site 21
Charlottesville, Virginia
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.